EGFR and cancer: Notably, the presence of major components of cancer signaling pathways such as PI3K/Akt, EGF/EGFR, RAS, JNK-MMP2/9, and estrogen makes lipid rafts a promising therapeutic target in anti-cancer therapy [3,4].